Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    Ruby Khatun Khatun
    Ruby Khatun Khatun
      • Home
      • Ruby Khatun Khatun

      Articles By : Ruby Khatun Khatun

      AbbVie wins reversal of 140 million dollar verdict in case over AndroGel risks

      AbbVie wins reversal of 140 million dollar verdict in case over AndroGel risks

      Ruby Khatun Khatun6 July 2018 9:45 AM IST
      A U.S. judge overturned a $140.1 million verdict against AbbVie Inc in a lawsuit by a man who claimed the company misrepresented the risks of its...
      Europe recalls generic heart drug made in China on cancer fears

      Europe recalls generic heart drug made in China on cancer fears

      Ruby Khatun Khatun6 July 2018 9:30 AM IST
      LONDON: A number of high blood pressure and heart drugs containing an ingredient made in China are being recalled across Europe after an impurity that...
      NPPA fixes prices of 58 formulations, details

      NPPA fixes prices of 58 formulations, details

      Ruby Khatun Khatun5 July 2018 1:55 PM IST
      New Delhi: Through a recent notification, Government of India, Ministry of Chemicals and Fertilizers, Department of Pharmaceuticals and National...
      Zydus Cadila gets USFDA nod to market Nifedipine extended-release tablets and Cholestyramine for oral suspension in US

      Zydus Cadila gets USFDA nod to market Nifedipine extended-release tablets and Cholestyramine for oral suspension in US

      Ruby Khatun Khatun5 July 2018 10:30 AM IST
      New Delhi: Drug firm Zydus Cadila said it has received final approval from the US health regulator to market Nifedipine extended-release tablets and...
      Strides Shasun gets USFDA approval for Ibuprofen and Milnacipran Hydrochloride tablets

      Strides Shasun gets USFDA approval for Ibuprofen and Milnacipran Hydrochloride tablets

      Ruby Khatun Khatun5 July 2018 10:15 AM IST
      New Delhi: Drug firm Strides Shasun said it has received approval from the US health regulator for anti-inflammatory Ibuprofen tablets and for...
      HealthifyMe crosses 5 Million registered users; becomes highest rated app

      HealthifyMe crosses 5 Million registered users; becomes highest rated app

      Ruby Khatun Khatun5 July 2018 10:00 AM IST
      Bangalore: HealthifyMe, India's most loved health app, today announced that it has crossed five million registered users on its mobile app platform....
      Suven Life gets product patents from India, S. Korea and Singapore

      Suven Life gets product patents from India, S. Korea and Singapore

      Ruby Khatun Khatun5 July 2018 9:45 AM IST
      New Delhi: Suven Life Sciences said it has been granted a product patent by India, Singapore, South Korea and Israel each for a new chemical entity...
      A 6 billion dollar china startup wants to be the Amazon of healthcare

      A 6 billion dollar china startup wants to be the Amazon of healthcare

      Ruby Khatun Khatun5 July 2018 9:30 AM IST
      As soon as you’re diagnosed as diabetic, ads for treatments show up on social feeds. You get alerts on health supplements, maybe nutrition tips....
      Fortis Bidding: Munjal-Burman stay away; IHH, Manipal-TPG still in fray

      Fortis Bidding: Munjal-Burman stay away; IHH, Manipal-TPG still in fray

      Ruby Khatun Khatun4 July 2018 2:00 PM IST
      New Delhi: Malaysia's IHH Healthcare and Manipal-TPG combine have put in fresh binding bids for cash-strapped healthcare chain while Munjal-Burman...
      Dr Reddys launches cholesterol lowering drug in India

      Dr Reddy's launches cholesterol lowering drug in India

      Ruby Khatun Khatun4 July 2018 10:30 AM IST
      New Delhi: Dr Reddy's Laboratories said it has launched Repatha, a cholesterol-lowering drug, in the country after getting approval from the health...
      Aurobindo Pharma gets approval to manufacture pain reliever Ibuprofen

      Aurobindo Pharma gets approval to manufacture pain reliever Ibuprofen

      Ruby Khatun Khatun4 July 2018 10:15 AM IST
      New Delhi: Aurobindo Pharma has received final approval from the US health regulator to manufacture and market Ibuprofen capsules, used to relieve...
      Sangam Health Cares former promoter settles case with SEBI, pays Rs 48 Lakh

      Sangam Health Care's former promoter settles case with SEBI, pays Rs 48 Lakh

      Ruby Khatun Khatun4 July 2018 10:00 AM IST
      New Delhi: Markets regulator SEBI has settled a case related to alleged disclosure lapses by an erstwhile promoter of pharmaceutical firm Sangam...
      PrevNext

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok